(HYGW) iShares Trust - iShares - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Derivative Income

HYGW: High Yield Bonds, Call Options

The iShares Trust - iShares High Yield Corporate Bond BuyWrite Strategy ETF (BATS:HYGW) employs a covered call strategy, writing European-style call options on the underlying fund. The fund ensures that the short call position is fully covered by the long position in the underlying shares, mitigating potential losses. The ETF focuses on high-yield corporate bonds, offering exposure to the debt of companies with lower credit ratings.

HYGW trades on the BATS exchange under the ticker symbol HYGW. It is classified as a high-yield bond ETF, originating from the United States. The funds assets under management (AUM) amount to $214.69 million, indicating a moderate size in the ETF market.

From a technical standpoint, HYGW shows a last price of $31.85, with key moving averages indicating a slightly bullish trend. The SMA 20 ($31.74) and SMA 50 ($31.63) are below the current price, while the SMA 200 ($31.14) is further below. Support levels are identified at $31.7 and $31.3, suggesting potential buying interest at these points. The ATR of 0.08 reflects low volatility, while the average 20-day volume of 39,216 shares indicates moderate trading activity.

3-Month Forecast: - Technical Outlook: HYGW is expected to trade within a narrow range, bounded by its support levels at $31.7 and $31.3. The SMA 20 and SMA 50, currently below the last price, suggest potential upside if the price maintains its current trajectory. - Fundamental Outlook: The high-yield bond market may face headwinds from rising interest rates, which could impact the ETFs performance. However, the covered call strategy may provide some cushion by generating income from option premiums. - Volatility: With an ATR of 0.08, HYGW is expected to experience minimal price fluctuations, making it a relatively stable investment in the near term. Overall, HYGW is anticipated to remain range-bound with a slight bullish bias, supported by its covered call strategy and moderate trading volumes. Investors seeking income with low volatility may find HYGW appealing, though they should be mindful of broader market conditions.

Additional Sources for HYGW ETF

HYGW ETF Overview

Market Cap in USD 218m
Category Derivative Income
TER 0.69%
IPO / Inception 2022-08-18

HYGW ETF Ratings

Growth 5y 57.7%
Fundamental -
Dividend 65.8%
Rel. Strength Industry 8.15
Analysts -
Fair Price Momentum 33.25 USD
Fair Price DCF -

HYGW Dividends

Dividend Yield 12m 10.95%
Yield on Cost 5y 12.54%
Annual Growth 5y 7.31%
Payout Consistency 92.3%

HYGW Growth Ratios

Growth Correlation 3m 79.9%
Growth Correlation 12m 98%
Growth Correlation 5y 98.1%
CAGR 5y 6.01%
CAGR/Max DD 5y 1.09
Sharpe Ratio 12m 1.26
Alpha 0.41
Beta 0.13
Volatility 3.91%
Current Volume 30.4k
Average Volume 20d 30.5k
What is the price of HYGW stocks?
As of March 09, 2025, the stock is trading at USD 31.59 with a total of 30,378 shares traded.
Over the past week, the price has changed by -0.16%, over one month by +0.36%, over three months by +0.45% and over the past year by +5.84%.
Is iShares Trust - iShares a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares Trust - iShares (BATS:HYGW) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 57.69 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HYGW as of March 2025 is 33.25. This means that HYGW is currently overvalued and has a potential downside of 5.25%.
Is HYGW a buy, sell or hold?
iShares Trust - iShares has no consensus analysts rating.
What are the forecast for HYGW stock price target?
According to ValueRays Forecast Model, HYGW iShares Trust - iShares will be worth about 36.1 in March 2026. The stock is currently trading at 31.59. This means that the stock has a potential upside of +14.34%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 36.1 14.3%